RenalSense Company

RenalSense is building a Realtime Diagnostic Platform for Acute Kidney Injury (AKI) in Critical Care: Detection, Prevention, Management
Technology: Diagnostic Pannel
Industry: P4 Medicine
Headquarters: Jerusalem, Yerushalayim, Israel
Founded Date: 2009-01-01
Employees Number: 11-50
Funding Status: N/A
Investors Number: 2
Total Funding: 14825832
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-11-22
Last Funding Type: Series A

Visit Website
paulwalt@netvision.net.il
http://www.renalsense.com
Register and Claim Ownership